BioTelemetry (BEAT) Tops Q3 EPS by 2c

Go back to BioTelemetry (BEAT) Tops Q3 EPS by 2c

BioTelemetry, Inc. Reports Third Quarter 2019 Financial Results

November 5, 2019 4:06 PM UTC

Exceeds ExpectationsDelivers Double Digit Revenue Growth

MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2019.

Quarter Highlights  

Recognized quarterly revenue of $111.3 millionReached 11.3% year-over-year revenue growthAchieved 29th consecutive quarter of year-over-year revenue growthReported GAAP net income of $8.3 millionRealized quarterly adjusted EBITDA of... More